ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borland, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borland, C.
Eur Respir J 2008; 31:918-919
Copyright ©ERS Journals Ltd 2008

A place for TL,NO with TL,CO?

C. Borland

CORRESPONDENCE: C. Borland, Hinchingbrooke Hospital, Huntingdon, Cambridgeshire, PE29 6NT, UK. Fax: 44 1480416561. E-mail: colin.borland{at}hinchingbrooke.nhs.uk

In 1915, Krogh 1 first measured the diffusion of carbon monoxide to demonstrate that oxygen passively diffused from the alveolus to pulmonary capillary blood. The history review by Hughes and Bates 2 discusses this excellently. Subsequently, in 1957, Roughton and Forster 3 demonstrated that CO diffusion measured by the diffusing capacity of the lung for CO (DL,CO) reflected both alveolar capillary membrane diffusion and reaction with pulmonary capillary blood. The overall resistance is:

1/ DL,CO = 1/Dm +1/{Theta}Vc (1)

where Dm is the membrane diffusing capacity, {Theta} the specific transfer conductance of the blood (measured by CO reaction with red cells using a rapid reaction apparatus) and Vc the pulmonary capillary blood volume 3. In healthy young volunteers, DL,CO is 30 mL·min–1 torr–1, Dm is 57 mL·min–1 torr–1 and Vc is 80 mL. To acknowledge that the overall process involved more than just diffusion, J. Cotes coined the term transfer factor of the lung for CO (TL,CO).

In 1982, T. Higenbottam and I were studying lung uptake and toxicity of NO in cigarette smokers; A. Chamberlain (our then research assistant) suggested that we measure this as transfer factor of the lung for NO (TL,NO). Quite independently, ~10 yrs earlier, the late D. Bargeton and H. Guénard had speculated that if another gas could be found that reacted with haemoglobin, by inhaling it simultaneously with CO, the equation of Roughton and Forster 3 could be solved for Dm and Vc in a single breath rather than by measuring TL,CO at two or more oxygen concentrations and cardiac outputs. NO reacts, in effect, instantly with haemoglobin. The resulting single-breath studies from our respective two groups 4, 5 generated much interest, including an editorial in the European Respiratory Journal (ERJ) 6. However, after 25 yrs, combined TL,NO and TL,CO is measured by only a few enthusiasts worldwide. In contrast, 25 yrs after the study by Roughton and Forster 3, TL,CO had become a standard lung function test in every clinical respiratory laboratory 7. Why this difference?

For CO, the technique has been standardised by the European Respiratory Society and the American Thoracic Society. Unfortunately for single breath TL,NO and TL,CO, there is no such standardisation; therefore, differing inspired NO concentrations and breath-hold times have been used and Dm and Vc have been calculated very differently. We chose 40 ppm NO originally as we calculated this as the alveolar NO concentration after a smoker inhales from a popular UK cigarette brand! Unlike CO, NO is oxidised to the toxic NO2 in air so the inhaled mixture has to be made immediately prior to inhalation. For NO there is disagreement about the ideal breath-hold time. The original description used 7.5 s rather than 10 s for TL,CO. We pragmatically chose this because >40 ppm NO in air is toxic and oxidised too rapidly, and the standard 10-s TL,CO breath-hold gave insufficient exhaled NO for our analyser to detect. Newer analysers are more sensitive, allowing inhaled concentrations as low as 4 ppm to be used with longer breath-holds; however, there is then concern about contamination by endogenous nasal and alveolar NO.

Clinicians and manufacturers have rightly questioned whether combining TL,CO with TL,NO justifies the practical difficulties, potential toxicity and expense. There is also disagreement about what is measured. Whilst nobody disagrees that the equation of Roughton and Forster 3 can be solved for the two gases yielding Dm and Vc, there has been disagreement regarding whether TL,NO is equal to or less than the membrane diffusing capacity of NO (Dm,NO). Guenard et al. 5 reasoned that because the reaction of NO with haemoglobin was instantaneous, {Theta}NO was, therefore, infinity so that rearrangement of the equation of Roughton and Forster 3 yielded:

1/Vc = {Theta}CO (1/TL,CO + a /TL,NO) (2)

and

TL,NO = Dm,NO = a Dm,CO(3)

The constant a equals the ratio of diffusivity of:

NO/CO = water solubility/{surd}molecular weight = 1.97 (4)

The results of Guenard et al. 5 for diffusing capacity of CO (Dm,CO) and Vc were very close to those obtained by the equation of Roughton and Forster 3 using TL,CO. Others have taken the pragmatic approach further. In 1957, in a combined group of healthy subjects and patients with sarcoidosis, a was found to be 2.42 8. Hence some groups have taken a as 2.42 rather than 1.97.

There are a number of scientific concerns about this pragmatic approach. First, laboratory estimates of {Theta}NO are substantially less than infinity, ~4.5 mL·min–1 torr–1. Using these estimates for {Theta}NO gives higher values for Dm and lower values for Vc 9. Secondly, in 1987, Forster 10 recalculated {Theta}CO at a physiological pH of 7.4 and obtained a different value, which he thought was the correct one. Using the value from 1987 and TL,CO at differing oxygen tensions also gives lower values for Vc and higher values for Dm, but one group have obtained negative values for 1/Dm making the values from 1987 unusable for the traditional two-step TL,CO approach in their sample 11. Thirdly, if a really is 2.42 as a result of chemical interaction with, say nitrosothiols in the alveolar capillary membrane, then arguably the assumption by Roughton and Forster 3 of diffusion but not chemical reaction in the membrane is violated. Irrespective of these concerns if the numbers generated for Dm and Vc are reproducible and help clinicians in the diagnosis and management of patients then they are worth using even if some scientists are uncertain of their exact physical and chemical basis.

For CO, large populations of healthy people were tested, giving reference equations based on height, age, sex and smoking status so that individuals with known or suspected lung disease could be tested and a "% predicted" or reference to a "normal range" (generally 1 SD) quoted. Until 2007, no such data existed for TL,NO. Within the last year three such papers have been published; one appears in the current issue of the ERJ 11. Aguilaniu et al. 11 have obtained statistically significant associations between TL,NO and age, height and sex. Current smokers were excluded. This growing body of reference data will assist those using TL,NO and TL,CO as a routine clinical respiratory function test. We commend them and the Montreal group 12 on consistency of breath-hold time (5.5 s), inspired NO concentration (40 ppm) and quoting results for Dm and Vc using both values for constant a. The other recent population reference data on TL,NO used an inhaled concentration of 7–9 ppm and a breath-hold time of 10 s consistent with standard TL,CO practice and did not calculate Dm,CO or Vc 13. Aguilaniu et al. 11 make a reasonable case for a short breath-hold time; apart from considerations of NO oxidation and detection, breathless patients may have difficulty holding their breath for 10 s.

Aguilaniu et al. 11 have also noted a difference in TL,NO between geographic locations and have speculated that this is due to pollution. There are good recent longitudinal data linking particulate matter and airway disease 14 but less that link gas transfer. Clearly, proof of causality would be difficult as dose–response data and robust longitudinal studies are needed. A more likely reason for differences is interlaboratory variation in technique and gas analysis, even if laboratories use identical equipment and algorithms. A study of a single individual tested in five laboratories in London, UK, showed that TL,CO varied from 10.5–20.4 mL·min–1 torr–1 15. In this context, the 8.5% difference in TL,CO is not unexpected. It was a pity that a subgroup of individuals could not be tested in both laboratories on several occasions over time in the study by Aguilaniu et al. 11.

Two other noteworthy developments in the last few years have occurred in TL,NO and TL,CO research. First, the Bordeaux group 16 have taken the mathematical analysis further, considering the pulmonary membrane and capillary as two rectangular boxes sharing a side of identical surface area. TL,NO/TL,CO can then be shown to be inversely proportional to the product of membrane and capillary blood layer thickness 16. TL,NO/TL,CO thus becomes an index of lung function irrespective of which value for a or {Theta}CO is used. Secondly, a prototype commercial instrument has now been produced with TL,NO, TL,CO, Dm and Vc capability (Masterscreen PFT; Viasys-Jaeger, Höchberg Germany). Undoubtedly, part of the success of the single-breath TL,CO test was that robust and practical measuring equipment that gave quick, painless and reproducible results was developed.

Will all these developments mean that combined transfer factor of the lung for NO and transfer factor of the lung for CO will become an essential test in all clinical respiratory function testing laboratories? Time will tell.

Statement of interest

A statement of Interest for C. Borland can be found at www.erj.ersjournals.com/misc/statements.shtml

ACKNOWLEDGEMENTS

The author is most grateful to M. Hughes and R. Buttery for their helpful comments.

REFERENCES

  1. Krogh M. The diffusion of gases through the lungs of man. J Physiol 1915;49:271–296.[Free Full Text]
  2. Hughes JM, Bates DV. Historical review: the carbon monoxide diffusing capacity (DLCO) and its membrane (DM) and red cell ({theta}Vc) components. Respir Physiol Neurobiol 2003;138:115–142.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  3. Roughton FJ, Forster RE. Relative importance of diffusion and chemical reaction in determining the rate of exchange of gases in the human lung. J Appl Physiol 1957;11:290–302.[Abstract/Free Full Text]
  4. Borland CD, Higenbottam TW. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide. Eur Respir J 1989;2:56–63.[Abstract]
  5. Guenard H, Varenne N, Vaida P. Determination of lung capillary blood volume and membrane diffusing capacity by measurement of NO and CO transfer. Respir Physiol 1987;70:113–120.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  6. Meyer M, Piiper J. Nitric Oxide (NO), a new test gas for study of alveolar-capillary diffusion. Eur Respir J 1989;2:494–496.[Web of Science][Medline] [Order article via Infotrieve]
  7. Forster RE. The single-breath carbon monoxide transfer test 25 years on: a reappraisal. Thorax 1983;38:1–9.[Free Full Text]
  8. Phansalkar AR, Hanson CD, Shakir AR, Johnson RL, Hsia CC. Nitric oxide diffusing capacity and alveolar microvascular recruitment in sarcoidosis. Am J Respir Crit Care Med 2004;169:1034–1040.[Abstract/Free Full Text]
  9. Borland C, Mist B, Zammit M, Vuylsteke A. Steady-state measurement of NO and CO lung diffusing capacity on moderate exercise in men. J Appl Physiol 2001;90:538–544.[Abstract/Free Full Text]
  10. Forster RE. Diffusion of gases across the alveolar membrane. In: Fishman AP, Fisher AB, eds. American Physiology Society Handbook of Physiology: Respiratory System Section 3. Gas Exchange. Vol. IV. Bethesda, Oxford University Press, 1987; pp. 71–78
  11. Aguilaniu B, Maitre J, Glénet S, Gegout-Petit A, Guénard H. European reference equations for CO and NO lung transfer. Eur Respir J 2008; 31: 1091–1097
  12. Zavorsky GS, Cao J, Murias JM. Reference values of pulmonary diffusing capacity for nitric oxide in an adult population. Nitric Oxide 2008;18:70–79.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  13. van der Lee I, Zanen P, Stigter N, van den Bosch JM, Lammers JW. Diffusing capacity for nitric oxide: reference values and dependence on alveolar volume. Respir Med 2007;101:1579–1584.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  14. Downs SH, Schindler C, Liu LJ, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007;357:2338–2347.[Abstract/Free Full Text]
  15. Saunders KB. Current practice in six London lung function laboratories. Proc Roy Soc Med 1977;70:162–163.[Web of Science][Medline] [Order article via Infotrieve]
  16. Glénet SN, De Bisschop C, Vargas F, Guénard HJ. Deciphering the nitric oxide to carbon monoxide lung transfer ratio: physiological implications. J Physiol 2007;582:767–775.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borland, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borland, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS